Elias Obeid

1.5k total citations
41 papers, 671 citations indexed

About

Elias Obeid is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Elias Obeid has authored 41 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Cancer Research and 16 papers in Genetics. Recurrent topics in Elias Obeid's work include BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Genomics and Diagnostics (9 papers). Elias Obeid is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Genomics and Diagnostics (9 papers). Elias Obeid collaborates with scholars based in United States, Canada and Norway. Elias Obeid's co-authors include Olufunmilayo I. Olopade, Rita Nanda, Yang‐Xin Fu, Suzanne D. Conzen, Michael J. Hall, Banu Arun, Mary B. Daly, Jasmina Bojadzieva, Kaylene Ready and Veda N. Giri and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Elias Obeid

39 papers receiving 663 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Elias Obeid 335 215 192 189 115 41 671
Priya B. Shetty 417 1.2× 313 1.5× 156 0.8× 297 1.6× 54 0.5× 23 874
Anne O’Dea 445 1.3× 233 1.1× 106 0.6× 96 0.5× 51 0.4× 45 716
Anosheh Afghahi 379 1.1× 138 0.6× 133 0.7× 249 1.3× 66 0.6× 37 590
Jenny Lester 239 0.7× 234 1.1× 140 0.7× 335 1.8× 77 0.7× 26 868
Ciara C. O’Sullivan 590 1.8× 299 1.4× 98 0.5× 293 1.6× 67 0.6× 72 1.0k
Jacques Raphael 541 1.6× 167 0.8× 64 0.3× 187 1.0× 105 0.9× 70 1.1k
Lesley Lomo 232 0.7× 133 0.6× 159 0.8× 206 1.1× 185 1.6× 27 707
Yasuhiro Yanagita 296 0.9× 291 1.4× 110 0.6× 190 1.0× 64 0.6× 44 1.0k
Marzena Wełnicka-Jaśkiewicz 610 1.8× 354 1.6× 76 0.4× 165 0.9× 41 0.4× 42 820
Tarah J. Ballinger 383 1.1× 217 1.0× 84 0.4× 285 1.5× 51 0.4× 49 727

Countries citing papers authored by Elias Obeid

Since Specialization
Citations

This map shows the geographic impact of Elias Obeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Obeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Obeid more than expected).

Fields of papers citing papers by Elias Obeid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Obeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Obeid. The network helps show where Elias Obeid may publish in the future.

Co-authorship network of co-authors of Elias Obeid

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Obeid. A scholar is included among the top collaborators of Elias Obeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Obeid. Elias Obeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obeid, Elias, Khaled Ezzedine, Sandrine Péneau, et al.. (2024). Meal timing and risk of metabolic syndrome in the prospective French NutriNet-Santé biobank. European Journal of Public Health. 34(Supplement_3). 1 indexed citations
2.
Gong, Yulan, Maria F. Arisi, Lorenzo Gerratana, et al.. (2021). Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International Journal of Molecular Sciences. 22(16). 8924–8924. 1 indexed citations
3.
Sokolova, Alexandra, Elias Obeid, & Heather H. Cheng. (2021). Genetic Contribution to Metastatic Prostate Cancer. Urologic Clinics of North America. 48(3). 349–363. 2 indexed citations
4.
Slifker, Michael, Jianming Pei, Jacqueline Talarchek, et al.. (2020). Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer. International Journal of Molecular Sciences. 21(4). 1290–1290. 12 indexed citations
5.
6.
Lynch, Shannon M., Elizabeth A. Handorf, Kristen A. Sorice, et al.. (2020). The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer. PLoS ONE. 15(8). e0237332–e0237332. 11 indexed citations
7.
Milliron, Brandy‐Joe, et al.. (2020). Physical activity assessment among men undergoing genetic counseling for inherited prostate cancer: a teachable moment for improved survivorship. Supportive Care in Cancer. 29(4). 2145–2151. 3 indexed citations
8.
Hedeker, Donald, Sarah M. Nielsen, Mary B. Daly, et al.. (2019). Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study. Cancer Medicine. 8(12). 5609–5618. 7 indexed citations
9.
Sigurdson, Elin R., Elizabeth A. Handorf, J.M. Daly, et al.. (2019). Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clinical Breast Cancer. 19(4). 292–303. 1 indexed citations
10.
Obeid, Elias, et al.. (2019). Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes. Annals of Surgical Oncology. 27(5). 1679–1692. 33 indexed citations
11.
Heath, Elisabeth I., Filipa Lynce, Joanne Xiu, et al.. (2018). Racial Disparities in the Molecular Landscape of Cancer. Anticancer Research. 38(4). 2235–2240. 45 indexed citations
12.
Giri, Veda N., Elias Obeid, Sarah Hegarty, et al.. (2018). Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling. The Prostate. 78(12). 879–888. 16 indexed citations
13.
Nanda, Rita, Erica Stringer-Reasor, Masha Kocherginsky, et al.. (2016). A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer. SpringerPlus. 5(1). 947–947. 30 indexed citations
14.
Hall, Michael J., et al.. (2016). Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond. Gynecologic Oncology. 140(3). 565–574. 34 indexed citations
15.
Roussi, Pagona, Suzanne M. Miller, Veda N. Giri, et al.. (2016). Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style. Journal of Health Psychology. 23(14). 1800–1809. 7 indexed citations
16.
Fleisher, Linda, et al.. (2015). Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project. Journal of Cancer Education. 31(1). 191–197. 6 indexed citations
17.
18.
Burness, Monika L., Elias Obeid, & Olufunmilayo I. Olopade. (2014). Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report. Clinical Breast Cancer. 15(2). e155–e158. 4 indexed citations
19.
Obeid, Elias, Rita Nanda, Yang‐Xin Fu, & Olufunmilayo I. Olopade. (2013). The role of tumor-associated macrophages in breast cancer progression. International Journal of Oncology. 43(1). 5–12. 169 indexed citations
20.
Melhem‐Bertrandt, Amal, Jasmina Bojadzieva, Kaylene Ready, et al.. (2011). Early onset HER2‐positive breast cancer is associated with germline TP53 mutations. Cancer. 118(4). 908–913. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priya B. Shetty Breakdown of academic impact, for papers by Anne O’Dea Breakdown of academic impact, for papers by Anosheh Afghahi Breakdown of academic impact, for papers by Jenny Lester Breakdown of academic impact, for papers by Ciara C. O’Sullivan Breakdown of academic impact, for papers by Jacques Raphael Breakdown of academic impact, for papers by Lesley Lomo Breakdown of academic impact, for papers by Yasuhiro Yanagita Breakdown of academic impact, for papers by Marzena Wełnicka-Jaśkiewicz Breakdown of academic impact, for papers by Tarah J. Ballinger
Rankless by CCL
2026